Standalone Non-Imaging Vibration-Controlled Ultrasound System

Concepts

• medical equipment
• ultrasound system
• standalone non-imaging vibration-controlled ultrasound system
• endoscopy and ultrasound framework
• a standalone non-imaging vibration-controlled ultrasound system
• system
• imaging
• controlled
• standalone
• ultrasound

Location

United Kingdom: Various Locations in the UK

Geochart for 1 buyers and 1 suppliers

NHS Supply Chain

Echosens

+−

Leaflet | Map tiles by Stamen Design, under CC BY 3.0. Data by OpenStreetMap, under ODbL.

Description

NHS Supply Chain intends to launch a National Framework Agreement for the provision of Ultrasound System to Quantify Liver and or Spleen Stiffness and Measure Liver Steatosis that includes the following. • The ability to measure liver stiffness to quantify fibrosis and cirrhosis. • The ability to measure fatty liver to quantify steatosis non-invasively. • The functionality of Vibration-Controlled Transient Elastography (VCTE) technology. • The ability to allow any clinical practitioners to use the system rather than a trained sonographer only. For the avoidance of doubt consumables will only be in scope of the proposed Framework if purchased alongside the types of equipment, as stated in any subsequent specification. Precise quantities are unknown. It is anticipated that initial expenditure will be in the region of £17,500,000 in the first year of this Framework Agreement, however this is approximate only and the values may vary depending on the requirements of those bodies purchasing under the Framework Agreement. The estimated value over the total Framework Agreement term (including any extension options) is anticipated to be in the region of £35,000,000. NHS Supply Chain engaged with suppliers that can provide a Standalone Non-Imaging Vibration-Controlled Ultrasound System to Quantify Liver and or Spleen Stiffness and Measure Liver Steatosis. The PIN 2024/S 000-039307 intended to identify such providers with a view to ultimately align this solution within the scope of Endoscopy and Ultrasound Framework which is due for renewal in November 2026. Suppliers capable of delivering such a solution have been invited to submit proposals to provide a route to market that enables access for the NHS during the interim period until the award of the new framework on 2nd November 2026.

Total Quantity or Scope

This market exercise will be for the provision of a Standalone Non-Imaging Vibration-Controlled Ultrasound System to Quantify Liver and or Spleen Stiffness and Measure Liver Steatosis that includes the following.

Award Detail

Renewal Options

Option to extend up to a total of 12 months

Award Criteria

CPV Codes

• 33100000 - Medical equipments

Indicators

• Options are available.

Legal Justification

NHS Supply Chain engaged with suppliers that can provide a Standalone Non-Imaging Vibration-Controlled Ultrasound System to Quantify Liver and or Spleen Stiffness and Measure Liver Steatosis. The PIN 2024/S 000-039307 intended to identify such providers, resulting in one Provider responding to the PIN. This is truly disruptive innovation as classified via the Medical Technology Innovation classification framework on the government website.

Other Information

** PREVIEW NOTICE, please check Find a Tender for full details. ** NHS Supply Chain have a mandate from DHSC to drive the availability of innovative products to the NHS. NHS Supply Chain believe the product sourced by this contract (which is not covered by any of its current Framework Agreements) falls within this remit as a “disruptive” innovative product and has been identified to provide enhanced patient benefits. This product will be utilised within the community allow more people to be accurately diagnosed with liver fibrosis and cirrhosis due to an increase in people either attending a scan at their GP surgery or because the system will be available “on the road” which may reduce health inequalities for people from disadvantaged or high-risk communities. The aim to bring liver scanning into GP settings also decreases the amount of in hospital needed care. This will proactively stop further hospital appointments and ultimately any long-term hospitalisation. There will also be a reduction in initial referrals and assessment appointments with hepatology allowing providers to use resources more efficiently. NHS Supply Chain intends to enter into a Framework Agreement (FAG) with an identified supplier of these products/services alongside the existing framework previously mentioned in ‘II.1.4) short description’ above) following a 10 calendar day publication of this notice should there only be only 1 available supplier using procedure 'Award of a contract without prior publication of a call for competition' as the procurement falls outside the scope of application of the Public Contracts Regulations. The Term of this Framework Agreement is anticipated to be 22 months. As part of its strategy, NHSSC anticipates engaging with suppliers of these products/services with a view to ultimately align this solution within the scope of Endoscopy and Ultrasound framework, which is due for renewal in November 2026. The Framework Agreement will be between NHS Supply Chain and the Supplier, however 1) NHSSC, 2) any NHS Trust; 3) any other NHS entity; 4) any government department, agency or other statutory body and/or 5) any private sector entity active in the UK healthcare sector will be able to enter into a direct contract with the Supplier for any of the supplies and/or services under the Framework. Electronic ordering will be used and electronic invoicing will be accepted and electronic payment will be used. For the avoidance of doubt and notwithstanding the estimate indicated at II.1.7, NHSSC does not guarantee any level of purchase through the framework. Any agreement entered will be considered a contract made in England according to English law and will be subject to the exclusive jurisdiction of the English Courts.